Net profit rose 14% year-over-year, with EBITDA up 2.4% and free cash flow nearly doubling. SG&A discipline, stable costs, and direct distribution support margin and volume growth, while no major price hikes are expected for the rest of the year.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.